Over 92% of leading pharmaceutical companies have exposed databases
Reposify's 2021 pharmaceutical external attack surface exposures report reveals alarming statistics.
Reposify, the leading external attack surface management platform, today released its Pharmaceutical Industry Attack Surface Exposures Report examining the security posture of the world's leading pharmaceutical companies.
Reposify's report analyzed eighteen leading pharmaceutical companies and their nine hundred plus subsidiaries worldwide to assess the prevalence of exposures of services, sensitive platforms, unpatched CVEs and other security issues.